Showing results (161-170 of 189) with videos related to

Sort By:
Pageof 19
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 26, 2024
Ghrelin decreases sensitivity to negative feedback and increases prediction-error related caudate activity in humans, a randomized controlled trialMichal Pietrzak, Adam Yngve, J Paul Hamilton, et al.
Brain Sciences|December 24, 2025
Innovations in Meta-Analytic and Computational Methods in the Neuroscientific Investigation of Psychiatric and Neurological DisordersChris H Miller, Thomas J Farrer, Jonathan D Moore, et al.
BMC Urology|April 17, 2016
Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a study protocol for a randomised controlled trialBonsan Bonne Lee, Swee-Ling Toh, Suzanne Ryan, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|January 15, 2026
Major Depressive Disorder in Youth and Adults: A Quantitative Whole-Brain Meta-Analysis of Functional Magnetic Resonance Imaging StudiesCaitlin Baten, Gladys Zamora, Amanda M Klassen, et al.
The Journal of Clinical Investigation|April 11, 2023
A randomized controlled experimental medicine study of ghrelin in value-based decision makingMichal Pietrzak, Adam Yngve, J Paul Hamilton, et al.
Spinal Cord|March 1, 2019
Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trialSwee-Ling Toh, Bonsan Bonne Lee, Suzanne Ryan, et al.
Molecular Psychiatry|April 11, 2023
Resilience to substance use disorder following childhood maltreatment: association with peripheral biomarkers of endocannabinoid function and neural indices of emotion regulationIrene Perini, Leah M Mayo, Andrea J Capusan, et al.
Metabolites|May 26, 2023
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic OptionsBilal Bashir, Jan H Ho, Paul Downie, et al.
Infectious Diseases and Therapy|December 16, 2023
Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II StudiesChris Wynne, Abundio Balgos, Jingxin Li, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 5, 2024
Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National RegistryBilal Bashir, Paul Downie, Natalie Forrester, et al.
Pageof 19